Determination of Methylamine in Drug Products

Significance of Topic

The accurate quantification of monomethylamine (MMA) in drug products is critical for ensuring product safety, regulatory compliance, and consistent manufacturing quality. MMA is a common process-related impurity and is regulated due to its toxicity and potential misuse. High-sensitivity analytical methods are therefore essential for monitoring trace levels of MMA in pharmaceutical formulations.

Goals and Study Overview

This study aimed to develop and validate a robust ion chromatography (IC) method using a reagent-free ion chromatography (RFIC) system with suppressed conductivity detection to determine MMA in pharmaceutical tablets. The approach sought to improve sensitivity relative to direct conductivity detection and to integrate automated eluent generation for enhanced reproducibility.

Methodology and Instrumentation

Samples of alfuzosin and sertraline hydrochloride tablets were ground, diluted in deionized water, and filtered. Both unspiked and MMA-spiked preparations were analyzed. An on-line cleanup step used a hydrophobic guard column to remove interfering compounds before transferring MMA onto a low-pressure cation concentrator and then to the analytical column.

• Analytical column: Dionex IonPac CS19 (4 × 250 mm) with CG19 guard (4 × 50 mm)
• Concentrator: Dionex IonPac TCC-LP1 (4 × 35 mm)
• Trap column: Dionex IonPac NG1-10 µm guard (4 × 35 mm)
• Eluent: Methanesulfonic acid (MSA) gradient (1.7 mM to 11 mM) generated by Dionex EGC III MSA cartridge and RFIC pump
• Detector: Dionex CSRS 300 suppressed conductivity, recycle mode, 33 mA
• Autosampler: Dionex AS-AP; Data system: Chromeleon CDS v7.1+

Main Results and Discussion

Separation of MMA from six common cations (Li⁺, Na⁺, NH₄⁺, K⁺, Mg²⁺, Ca²⁺) was achieved with sharp, well-resolved peaks. Linearity was confirmed over 10–50 µg/L with a coefficient of determination (r²) of 0.9991. The method detection limit (MDL), defined as three times signal-to-noise, was 1.2 µg/L—significantly lower than values reported for nonsuppressed detection.
Analysis of spiked and unspiked drug samples yielded MMA recoveries of 104–113% in alfuzosin and 99.8–106% in sertraline hydrochloride, with relative standard deviations below 2.1%. MMA was detected only in sertraline samples (15.6–33.2 µg/L).

Benefits and Practical Applications

The RFIC method offers:

• Enhanced sensitivity via suppressed conductivity detection
• Automated, reproducible eluent generation to eliminate manual preparation errors
• Integrated on-line cleanup for cleaner baselines and extended column life
• Throughput of approximately 32 minutes per sample

This workflow is readily adaptable for routine quality control of drug substances where amine impurities must be monitored.

Future Trends and Potential Applications

Emerging opportunities include:

• Extension to other primary and secondary amines in pharmaceuticals
• Coupling RFIC with mass spectrometry for enhanced selectivity
• Miniaturized systems for high-throughput or field analysis
• Green chemistry approaches to reduce reagent consumption and waste

Conclusion

A fully automated RFIC method with suppressed conductivity detection was successfully developed for MMA quantification in drug tablets. The approach demonstrated excellent sensitivity, linearity, precision, and accuracy, supporting its application in pharmaceutical quality control.

References

1. Wikipedia. Methylamine. Accessed April 26, 2013.
2. Kumar KS et al. Determination and Validation of Monomethylamine Content by Ion Chromatography in Pharmaceutical Substances. Der Pharma Chemica, 2010;2(3):277–287.
3. Thermo Scientific Application Note 298: Determination of Dimethylamine in Metformin HCl Using IC with Suppressed Conductivity Detection. 2012.
4. Dionex Application Note 199: Determination of N-Methylpyrrolidine in Cefepime Using RFIC. 2008.
5. Dionex Application Note 259: Determination of N-Methylpyrrolidine in Cefepime with Nonsuppressed Conductivity Detection. 2010.